The price of dominance

Summary: Clean Science combines rare process-driven dominance, strong margins and a debt-free balance sheet, yet its stock has struggled as growth slowed and Chinese competition intensified. Here, we check whether the company’s next phase of products and expansion can reignite growth and justify renewed investor confidence.

Summary: Clean Science combines rare process-driven dominance, strong margins and a debt-free balance sheet, yet its stock has struggled as growth slowed and Chinese competition intensified. Here, we check whether the company’s next phase of products and expansion can reignite growth and justify renewed investor confidence. Revenue has stalled for two years. The stock has fallen sharply from its post-listing highs. And yet, Clean Science and Technology remains the world’s largest manufacturer of four speciality chemicals, runs margins that most Indian companies can only dream of and carries no debt whatsoever. The gap between what the business is and what the stock has done lately is what makes it interesting. A certain kind of dominance Clean Science makes chemicals that most people cannot name but quietly depend on. MEHQ goes into diapers and acrylic fibres as a stabiliser. BHA preserves food and animal feed. 4-MAP is a UV blocker used in sunscreens. Anisole finds its way into perfumes and pharmaceuticals. None of these is glamorous. All of them are critical. The company is the world’s largest manufacturer of each, by installed capacity. It holds about 55 per cent of global MEHQ capacity alone. What built that position is not size or spending but process. Two of its four founders, Ashok Boob and Siddharth Sikchi, are alumni of the Insti